Personally, I believe he will try and convert as many as he possibly can with a positive sentiment as it shows his commitment. Imagine a scenario where their goal of a GW Pharma market cap is reached. I think it sits around the USD 6.4B or AUD 9B dollar mark. It looks like IHL is around AUD 0.337B as of today. I hope my rough maths and understanding is correct.
9.000B / 0.337B = A factor of 26.7
If he converted his 20c options i think he will end up with around $60 million plus a wee bit more.
$60 million X 26.7 = a potential $1.6 Billion.
If I was him, I think the only thing worse than not potentially making so much money would be not giving it a go and living with it. I don't for a second believe that he is the kind of person that wouldn't at the very least give it a crack. I've never met any of the board but based on their strategy and current achievements with IHL i think it is fair to say that there are a few good heads on those shoulders. Markets with unmet pharmacological needs using combinations of drugs that have already been proven and fast results using previous data. I could go on and on.
This confirmation, although not completion, of the Nasdaq listing in my opinion cements in where this is heading. TBH, I had originally pegged the share price at around $5 in around 4-5 years only being on the ASX but with confirmation of heading to the US of A, I dont see why a larger price is not possible.
And just for a laugh, I thought i would pull out my woooorst case scenario of a factor of 3 which would take his $40m conversion, which then turns directly into $60m if converted today which then turns into $180m (60x3). Pretty much black and white.
Sorry for banging on but the comment from Lupe started to wind me up as I strongly disagree. Clearly this is my own opinion.
IHL Price at posting:
32.0¢ Sentiment: Buy Disclosure: Held